Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Mark Comer
University of Cambridge
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
171
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
In Vivo Screen in Benign Prostate Epithelium Identifies Loss of α-Catenin as a Driver of Metastasis and Androgen Insensitivity
Number of pages: 36
Posted: 24 Nov 2025
Mark Comer,
Alexandra Hart
,
Henson Lee Yu
,
Liliya Nazlamova
,
Toby Milne-Clark
,
John Thomas
,
Vijaya Mahalingam
,
Lisa Dobson
,
Tamsin Robb
,
Filipa Palma-Reis Goldie
,
Katta Hautaviita
,
Ahmed Elwakeel
,
Sarah Field
,
Nikolaos Patikas
,
Holly Barber
,
Melissa Cheung
,
Laura Machesky
,
Ivan Fernandez-Vega
,
Emmanouil Metzakopian
,
Allan Bradley
,
Harveer Dev
and
Jorge de la Rosa
University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, Wellcome Sanger Institute - Wellcome Genome Campus, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, University of Cambridge, Wellcome Sanger Institute - Wellcome Genome Campus, Harvard University - Harvard Medical School, University of Cambridge, University of Cambridge, University of Cambridge, Health Research Institute of Principado de Asturias (ISPA), Independent, Babraham Research Campus, University of Cambridge and Altos Labs
Downloads
171
(447,215)
View PDF
Download
Abstract:
Metastatic prostate cancer, Catenin-A1, EMT, CRISPR
Feedback